Efficacy of medical abortion prior to 6 gestational weeks: a systematic review
- PMID:28935220
- DOI: 10.1016/j.contraception.2017.09.006
Efficacy of medical abortion prior to 6 gestational weeks: a systematic review
Abstract
Objective: The objective was to describe the efficacy of medical abortion using mifepristone and misoprostol for gestations less than 6 weeks.
Study design: We searched PubMed and Cochrane databases for articles in any language that examined the success of mifepristone and misoprostol abortion at gestational ages <42 days. Data were independently abstracted by two authors and graded for evidence quality. A pooled analysis of efficacy and a summary odds ratio of abortion failure of <42 days' gestation compared with gestational week 42-49 days were performed for randomized trials as well as for prospective studies.
Results: Six randomized controlled trials and nine prospective observational studies met inclusion criteria. Included studies varied greatly in regimens of mifepristone and misoprostol used, and assessment of and timing of outcome of abortion. A pooled proportion of the randomized trials estimated a proportion of unsuccessful abortion of 0.02 (95% confidence interval 0.01-0.03). In the prospective studies, the proportions ranged between 0.02 and 0.17, with considerable heterogeneity in the pooled estimate. However, the two largest observational studies reflected the estimates of the randomized trials (range 0.02-0.03). The summary odds ratios indicated that the odds of unsuccessful abortion were not significantly different between gestational age groups (<42 days versus >42-49 days).
Discussion: These analyses support the use of medical abortion at gestational ages <42 days. Efficacy rates are high overall and appear to reflect those observed during the seventh week of pregnancy. Women who prefer to initiate treatment as soon as early pregnancy is diagnosed may do so without delay.
Implications: Women can expect success using medical abortion regimens as soon as pregnancy is diagnosed; further research of abortion outcomes disaggregated by gestational age and visualization of the gestational sac is warranted.
Keywords: Early medical abortion; Medical abortion efficacy; Mifepristone; Misoprostol.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
- The efficacy of medical abortion: a meta-analysis.Kahn JG, Becker BJ, MacIsaa L, Amory JK, Neuhaus J, Olkin I, Creinin MD.Kahn JG, et al.Contraception. 2000 Jan;61(1):29-40. doi: 10.1016/s0010-7824(99)00115-8.Contraception. 2000.PMID:10745067
- Medical abortion in the late first trimester: a systematic review.Kapp N, Eckersberger E, Lavelanet A, Rodriguez MI.Kapp N, et al.Contraception. 2019 Feb;99(2):77-86. doi: 10.1016/j.contraception.2018.11.002. Epub 2018 Nov 13.Contraception. 2019.PMID:30444970Free PMC article.
- Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.Chen MJ, Creinin MD.Chen MJ, et al.Obstet Gynecol. 2015 Jul;126(1):12-21. doi: 10.1097/AOG.0000000000000897.Obstet Gynecol. 2015.PMID:26241251Review.
- Medical methods for first trimester abortion.Kulier R, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A.Kulier R, et al.Cochrane Database Syst Rev. 2004;(1):CD002855. doi: 10.1002/14651858.CD002855.pub2.Cochrane Database Syst Rev. 2004.Update in:Cochrane Database Syst Rev. 2004;(2):CD002855. doi: 10.1002/14651858.CD002855.pub3.PMID:14973995Updated.Review.
- First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.Raymond EG, Shannon C, Weaver MA, Winikoff B.Raymond EG, et al.Contraception. 2013 Jan;87(1):26-37. doi: 10.1016/j.contraception.2012.06.011. Epub 2012 Aug 13.Contraception. 2013.PMID:22898359Review.
Cited by
- Abortion Surveillance - United States, 2018.Kortsmit K, Jatlaoui TC, Mandel MG, Reeves JA, Oduyebo T, Petersen E, Whiteman MK.Kortsmit K, et al.MMWR Surveill Summ. 2020 Nov 27;69(7):1-29. doi: 10.15585/mmwr.ss6907a1.MMWR Surveill Summ. 2020.PMID:33237897Free PMC article.
- Combination of medical and surgical management in successful treatment of caesarean scar pregnancy: a case report series.Pristavu A, Vinturache A, Mihalceanu E, Pintilie R, Onofriescu M, Socolov D.Pristavu A, et al.BMC Pregnancy Childbirth. 2020 Oct 13;20(1):617. doi: 10.1186/s12884-020-03237-8.BMC Pregnancy Childbirth. 2020.PMID:33050911Free PMC article.
- Abortion Surveillance - United States, 2020.Kortsmit K, Nguyen AT, Mandel MG, Clark E, Hollier LM, Rodenhizer J, Whiteman MK.Kortsmit K, et al.MMWR Surveill Summ. 2022 Nov 25;71(10):1-27. doi: 10.15585/mmwr.ss7110a1.MMWR Surveill Summ. 2022.PMID:36417304Free PMC article.
- A Retrospective Cost-Effectiveness Analysis of Mifepristone-Misoprostol Medical Abortions in the First Year at the Regina General Hospital.Hunter C, Jensen J, Imeah B, McCarron M, Clark M.Hunter C, et al.J Obstet Gynaecol Can. 2021 Feb;43(2):211-218. doi: 10.1016/j.jogc.2020.08.008. Epub 2020 Aug 25.J Obstet Gynaecol Can. 2021.PMID:33153943Free PMC article.
- A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion.Kapp N, Mao B, Menzel J, Eckersberger E, Saphonn V, Rathavy T, Pearson E.Kapp N, et al.BMJ Sex Reprod Health. 2023 Oct;49(4):300-307. doi: 10.1136/bmjsrh-2022-201722. Epub 2023 Mar 9.BMJ Sex Reprod Health. 2023.PMID:36894309Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous